Actively Recruiting
Alpha Ketoglutarate Enhances Geroprotection In Surgery (AEGIS)
Led by National University Hospital, Singapore · Updated on 2025-06-22
250
Participants Needed
2
Research Sites
129 weeks
Total Duration
On this page
Sponsors
N
National University Hospital, Singapore
Lead Sponsor
W
Wellcome Leap Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
One of the most common major surgeries that older patients undergo is coronary artery bypass grafting surgery (CABG), which is performed in approximately 400,000 patients in the United States each year. CABG invokes a massive surgical stress response, with systemic epinephrine increasing 33-fold and norepinephrine increasing 3-fold. Initially, local tissue injury results in a sterile inflammation, releasing damage-associated molecular patterns (DAMPS). DAMPS activate neutrophils, bringing a cascade of cytokines, complement, and coagulation changes. Activation of nociceptors results in a neurometabolic response involving the sympathetic nervous system and hypothalamus-pituitary axis. This brings about systemic effects including changes in basal metabolic rate, hyperglycemia, lipolysis, negative nitrogen balance, and release of cytokines and complement. Although the surgical stress response is essential for wound healing and is usually self-limiting, an exaggerated response may occur resulting in multiple organ dysfunction. The acute phase of the surgical stress response is often followed by secondary insults that may be either sterile or pathogen-induced (such as postoperative infection).In the "two-hit" model of surgical stress response, there is an exaggerated response even to minor insults in vulnerable individuals who were primed by the initial stress response. Changes in the microbiome may also occur, developing a "pathobiome" that may enter the systemic circulation. If left unchecked, this second hit may result in the development of systemic inflammatory response syndrome (SIRS) and multi-organ failure. Chronological ageing changes the innate and adaptive immunity of patients. Biological hallmarks of aging such as genomic instability, mitochondrial damage, glycation of proteins, and cellular senescence all result in increased oxidative stress and systemic inflammation. Aging brings about a pro-inflammatory innate immune responsiveness that often occurs even in the absence of an inflammatory threat. This is termed inflammaging. Paradoxically, inflammaging is associated with an increased risk of infection and poor response to stressful events. At the same time, there is an age-associated loss of T-cell function, particularly in naïve CD8 T-cells. This deficit is termed immunosenescence and is characterised by reduced pathogen recognition, chemotaxis, and phagocytosis.
CONDITIONS
Official Title
Alpha Ketoglutarate Enhances Geroprotection In Surgery (AEGIS)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Scheduled for elective coronary artery bypass grafting with cardiopulmonary bypass
- Aged 50 years or older
- Able to understand and provide informed consent
You will not qualify if you...
- Currently taking alpha-ketoglutarate supplements
- Untreated or treated substance abuse disorder
- Untreated or poorly controlled mental health conditions such as post-traumatic stress disorder, bipolar disorder, schizophrenia, or recent hospitalization for mental health in the past 3 years
- Cognitive impairment
- HIV/AIDS
- Undergoing or planning chemotherapy or other cancer treatments
- Scheduled for immunosuppressant therapy for transplant
- Active infection needing antibiotic or antiviral treatment
- Pregnant, planning to conceive, or breastfeeding
- Taking chronic anti-inflammatory drugs like NSAIDs
- Allergic to alpha-ketoglutarate, placebo, or any tablet components
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
National University Hospital
Singapore, Singapore, Singapore, 119074
Actively Recruiting
2
Singapore General Hospital
Singapore, Singapore
Actively Recruiting
Research Team
L
Lian Kah Ti
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here